AI-Powered question lists could help blood cancer patients get more from doctor visits
NCT ID NCT07226934
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an AI-generated personalized question prompt list (GPT-QPL) can help people with lymphoma or multiple myeloma ask more useful questions during their outpatient appointments. Researchers will create tailored question lists for 40 patients using ChatGPT, then measure changes in how confident patients feel communicating with their doctors and how satisfied they are with the information they receive. The goal is to see if this simple AI tool is feasible and helpful for improving patient-doctor communication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GPT-QPL (AI-generated personalized question prompt list)
What this could lead to
If it works, this could give patients a simple tool to get more useful information from their doctors and feel more in control of their care.
What could go wrong
This is a very small, early feasibility study with only 40 participants, so results may not apply to everyone. The AI tool may not be helpful or easy to use for all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact